MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE)
- Anaplastic thyroid carcinoma with BRAF v600E mutation
- Malignant melanoma with BRAF v600E mutation
- Malignant melanoma with BRAF v600K mutation
- Non-small cell lung cancer with BRAF v600E mutation
0.5 mg tablet
- 2 tablets (1 mg) by oral route once daily at least 1 hour beforeor 2 hours after meals
2 mg tablet
- 1 tablet (2 mg) by oral route once daily at least 1 hour before or 2 hours after meals
Anaplastic thyroid carcinoma with BRAF v600E mutation
- 2 tablets (1 mg) by oral route once daily at least 1 hour beforeor 2 hours after meals
- 1 tablet (2 mg) by oral route once daily at least 1 hour before or 2 hours after meals
Malignant melanoma with BRAF v600E mutation
- 2 tablets (1 mg) by oral route once daily at least 1 hour beforeor 2 hours after meals
- 1 tablet (2 mg) by oral route once daily at least 1 hour before or 2 hours after meals
Malignant melanoma with BRAF v600K mutation
- 2 tablets (1 mg) by oral route once daily at least 1 hour beforeor 2 hours after meals
- 1 tablet (2 mg) by oral route once daily at least 1 hour before or 2 hours after meals
Non-small cell lung cancer with BRAF v600E mutation
- 2 tablets (1 mg) by oral route once daily at least 1 hour beforeor 2 hours after meals
- 1 tablet (2 mg) by oral route once daily at least 1 hour before or 2 hours after meals
- None
Contraindicated
- None
Severe
Moderate
- None
- Interstitial lung disease
- Lactating mother
- Retinal vascular occlusion
- Thrombosis of retinal vein
Contraindicated
- Cardiomyopathy
- Chronic heart failure
- Deep venous thrombosis
- High fever >101 degrees fahrenheit
- Increased risk of bleeding
- Pregnancy
- Pulmonary thromboembolism
- Retinal detachment
Severe
Moderate
- Gastrointestinal perforation
- Hyperglycemia
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE)
- Anaplastic thyroid carcinoma with BRAF v600E mutation
- Malignant melanoma with BRAF v600E mutation
- Malignant melanoma with BRAF v600K mutation
- Non-small cell lung cancer with BRAF v600E mutation
- Anemia
- Hypoalbuminemia
- Lymphopenia
- Neutropenic disorder
- Palmar-plantar erythrodysesthesia
- Skin rash
- Abnormal hepatic function tests
- Acneiform eruption
- Anorexia
- Chills
- Constipation
- Diarrhea
- Dyspnea
- Edema
- Erythema
- Fever
- Hyperglycemia
- Lymphedema
- Myalgias
- Nausea
- Night sweats
- Peripheral edema
- Skin inflammation
- Vomiting
More Frequent
Severe
Less Severe
- Cardiomyopathy
- Cellulitis
- Deep venous thrombosis
- Folliculitis
- Heart failure
- Hemorrhage
- Hypertension
- Hyponatremia
- Interstitial lung disease
- Interstitial pneumonitis
- Keratoacanthoma
- Pulmonary thromboembolism
- Squamous cell carcinoma
- Squamous cell carcinoma of skin
- Thrombocytopenic disorder
- Venous thrombosis
- Acute abdominal pain
- Basal cell carcinoma of skin
- Blurred vision
- Bradycardia
- Dizziness
- Dry eye
- Dry skin
- Dysgeusia
- Paronychia
- Pruritus of skin
- Stomatitis
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Colitis
- Gastrointestinal perforation
- Iritis
- Macular retinal edema
- Malignancy
- Retinal detachment
- Retinal vascular occlusion
- Rhabdomyolysis
- Second primary melanoma
- Tear of retinal pigment epithelium
- Uveitis
- Visual changes
Less Severe
- Glaucoma
- Reduced visual acuity
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Trametinib
Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
Trametinib
- Severity Level:
D
- Additional Notes: Based on drug pharmacology developmental toxicity is possible
Contraindicated
Trametinib
Insuff human data;Based on pharmacology, potential for infant adverse outcome
General | Excretion Potential | Effect on Infant | Notes |
Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Insuff human data;Based on pharmacology, potential for infant adverse outcome |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Trametinib
General-In combination with dabrafenib, elderly patients may be at increased risk of peripheral edema and anorexia.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | N | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
Anaplastic thyroid carcinoma with BRAF v600E mutation | |
C73 | Malignant neoplasm of thyroid gland |
Malignant melanoma with BRAF v600E mutation | |
C43 | Malignant melanoma of skin |
C43.0 | Malignant melanoma of lip |
C43.1 | Malignant melanoma of eyelid, including canthus |
C43.10 | Malignant melanoma of unspecified eyelid, including canthus |
C43.11 | Malignant melanoma of right eyelid, including canthus |
C43.111 | Malignant melanoma of right upper eyelid, including canthus |
C43.112 | Malignant melanoma of right lower eyelid, including canthus |
C43.12 | Malignant melanoma of left eyelid, including canthus |
C43.121 | Malignant melanoma of left upper eyelid, including canthus |
C43.122 | Malignant melanoma of left lower eyelid, including canthus |
C43.2 | Malignant melanoma of ear and external auricular canal |
C43.20 | Malignant melanoma of unspecified ear and external auricular canal |
C43.21 | Malignant melanoma of right ear and external auricular canal |
C43.22 | Malignant melanoma of left ear and external auricular canal |
C43.3 | Malignant melanoma of other and unspecified parts of face |
C43.30 | Malignant melanoma of unspecified part of face |
C43.31 | Malignant melanoma of nose |
C43.39 | Malignant melanoma of other parts of face |
C43.4 | Malignant melanoma of scalp and neck |
C43.5 | Malignant melanoma of trunk |
C43.51 | Malignant melanoma of anal skin |
C43.52 | Malignant melanoma of skin of breast |
C43.59 | Malignant melanoma of other part of trunk |
C43.6 | Malignant melanoma of upper limb, including shoulder |
C43.60 | Malignant melanoma of unspecified upper limb, including shoulder |
C43.61 | Malignant melanoma of right upper limb, including shoulder |
C43.62 | Malignant melanoma of left upper limb, including shoulder |
C43.7 | Malignant melanoma of lower limb, including hip |
C43.70 | Malignant melanoma of unspecified lower limb, including hip |
C43.71 | Malignant melanoma of right lower limb, including hip |
C43.72 | Malignant melanoma of left lower limb, including hip |
C43.8 | Malignant melanoma of overlapping sites of skin |
C43.9 | Malignant melanoma of skin, unspecified |
Malignant melanoma with BRAF v600K mutation | |
C43 | Malignant melanoma of skin |
C43.0 | Malignant melanoma of lip |
C43.1 | Malignant melanoma of eyelid, including canthus |
C43.10 | Malignant melanoma of unspecified eyelid, including canthus |
C43.11 | Malignant melanoma of right eyelid, including canthus |
C43.111 | Malignant melanoma of right upper eyelid, including canthus |
C43.112 | Malignant melanoma of right lower eyelid, including canthus |
C43.12 | Malignant melanoma of left eyelid, including canthus |
C43.121 | Malignant melanoma of left upper eyelid, including canthus |
C43.122 | Malignant melanoma of left lower eyelid, including canthus |
C43.2 | Malignant melanoma of ear and external auricular canal |
C43.20 | Malignant melanoma of unspecified ear and external auricular canal |
C43.21 | Malignant melanoma of right ear and external auricular canal |
C43.22 | Malignant melanoma of left ear and external auricular canal |
C43.3 | Malignant melanoma of other and unspecified parts of face |
C43.30 | Malignant melanoma of unspecified part of face |
C43.31 | Malignant melanoma of nose |
C43.39 | Malignant melanoma of other parts of face |
C43.4 | Malignant melanoma of scalp and neck |
C43.5 | Malignant melanoma of trunk |
C43.51 | Malignant melanoma of anal skin |
C43.52 | Malignant melanoma of skin of breast |
C43.59 | Malignant melanoma of other part of trunk |
C43.6 | Malignant melanoma of upper limb, including shoulder |
C43.60 | Malignant melanoma of unspecified upper limb, including shoulder |
C43.61 | Malignant melanoma of right upper limb, including shoulder |
C43.62 | Malignant melanoma of left upper limb, including shoulder |
C43.7 | Malignant melanoma of lower limb, including hip |
C43.70 | Malignant melanoma of unspecified lower limb, including hip |
C43.71 | Malignant melanoma of right lower limb, including hip |
C43.72 | Malignant melanoma of left lower limb, including hip |
C43.8 | Malignant melanoma of overlapping sites of skin |
C43.9 | Malignant melanoma of skin, unspecified |
Non-small cell lung cancer with BRAF v600E mutation | |
C34 | Malignant neoplasm of bronchus and lung |
C34.0 | Malignant neoplasm of main bronchus |
C34.00 | Malignant neoplasm of unspecified main bronchus |
C34.01 | Malignant neoplasm of right main bronchus |
C34.02 | Malignant neoplasm of left main bronchus |
C34.1 | Malignant neoplasm of upper lobe, bronchus or lung |
C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
C34.3 | Malignant neoplasm of lower lobe, bronchus or lung |
C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
C34.8 | Malignant neoplasm of overlapping sites of bronchus and lung |
C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
C34.9 | Malignant neoplasm of unspecified part of bronchus or lung |
C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
0-9 | A-Z |
---|---|
C34 | Malignant neoplasm of bronchus and lung |
C34.0 | Malignant neoplasm of main bronchus |
C34.00 | Malignant neoplasm of unspecified main bronchus |
C34.01 | Malignant neoplasm of right main bronchus |
C34.02 | Malignant neoplasm of left main bronchus |
C34.1 | Malignant neoplasm of upper lobe, bronchus or lung |
C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
C34.3 | Malignant neoplasm of lower lobe, bronchus or lung |
C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
C34.8 | Malignant neoplasm of overlapping sites of bronchus and lung |
C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
C34.9 | Malignant neoplasm of unspecified part of bronchus or lung |
C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
C43 | Malignant melanoma of skin |
C43 | Malignant melanoma of skin |
C43.0 | Malignant melanoma of lip |
C43.0 | Malignant melanoma of lip |
C43.1 | Malignant melanoma of eyelid, including canthus |
C43.1 | Malignant melanoma of eyelid, including canthus |
C43.10 | Malignant melanoma of unspecified eyelid, including canthus |
C43.10 | Malignant melanoma of unspecified eyelid, including canthus |
C43.11 | Malignant melanoma of right eyelid, including canthus |
C43.11 | Malignant melanoma of right eyelid, including canthus |
C43.111 | Malignant melanoma of right upper eyelid, including canthus |
C43.111 | Malignant melanoma of right upper eyelid, including canthus |
C43.112 | Malignant melanoma of right lower eyelid, including canthus |
C43.112 | Malignant melanoma of right lower eyelid, including canthus |
C43.12 | Malignant melanoma of left eyelid, including canthus |
C43.12 | Malignant melanoma of left eyelid, including canthus |
C43.121 | Malignant melanoma of left upper eyelid, including canthus |
C43.121 | Malignant melanoma of left upper eyelid, including canthus |
C43.122 | Malignant melanoma of left lower eyelid, including canthus |
C43.122 | Malignant melanoma of left lower eyelid, including canthus |
C43.2 | Malignant melanoma of ear and external auricular canal |
C43.2 | Malignant melanoma of ear and external auricular canal |
C43.20 | Malignant melanoma of unspecified ear and external auricular canal |
C43.20 | Malignant melanoma of unspecified ear and external auricular canal |
C43.21 | Malignant melanoma of right ear and external auricular canal |
C43.21 | Malignant melanoma of right ear and external auricular canal |
C43.22 | Malignant melanoma of left ear and external auricular canal |
C43.22 | Malignant melanoma of left ear and external auricular canal |
C43.3 | Malignant melanoma of other and unspecified parts of face |
C43.3 | Malignant melanoma of other and unspecified parts of face |
C43.30 | Malignant melanoma of unspecified part of face |
C43.30 | Malignant melanoma of unspecified part of face |
C43.31 | Malignant melanoma of nose |
C43.31 | Malignant melanoma of nose |
C43.39 | Malignant melanoma of other parts of face |
C43.39 | Malignant melanoma of other parts of face |
C43.4 | Malignant melanoma of scalp and neck |
C43.4 | Malignant melanoma of scalp and neck |
C43.5 | Malignant melanoma of trunk |
C43.5 | Malignant melanoma of trunk |
C43.51 | Malignant melanoma of anal skin |
C43.51 | Malignant melanoma of anal skin |
C43.52 | Malignant melanoma of skin of breast |
C43.52 | Malignant melanoma of skin of breast |
C43.59 | Malignant melanoma of other part of trunk |
C43.59 | Malignant melanoma of other part of trunk |
C43.6 | Malignant melanoma of upper limb, including shoulder |
C43.6 | Malignant melanoma of upper limb, including shoulder |
C43.60 | Malignant melanoma of unspecified upper limb, including shoulder |
C43.60 | Malignant melanoma of unspecified upper limb, including shoulder |
C43.61 | Malignant melanoma of right upper limb, including shoulder |
C43.61 | Malignant melanoma of right upper limb, including shoulder |
C43.62 | Malignant melanoma of left upper limb, including shoulder |
C43.62 | Malignant melanoma of left upper limb, including shoulder |
C43.7 | Malignant melanoma of lower limb, including hip |
C43.7 | Malignant melanoma of lower limb, including hip |
C43.70 | Malignant melanoma of unspecified lower limb, including hip |
C43.70 | Malignant melanoma of unspecified lower limb, including hip |
C43.71 | Malignant melanoma of right lower limb, including hip |
C43.71 | Malignant melanoma of right lower limb, including hip |
C43.72 | Malignant melanoma of left lower limb, including hip |
C43.72 | Malignant melanoma of left lower limb, including hip |
C43.8 | Malignant melanoma of overlapping sites of skin |
C43.8 | Malignant melanoma of overlapping sites of skin |
C43.9 | Malignant melanoma of skin, unspecified |
C43.9 | Malignant melanoma of skin, unspecified |
C73 | Malignant neoplasm of thyroid gland |